Abstract:Abstract Glioma is an extremely aggressive malignant neoplasm of the central nervous system. MicroRNA (miRNA) are known to bind to specific target mRNA to regulate post-transcriptional gene expression and are, therefore, currently regarded as promising biomarkers for glioma diagnosis and prognosis. The aim of the present study was to examine the pathogenesis and potential molecular markers of glioma by comparing the differential expression of miRNA and mRNA between glioma tissue and peritumor brain tissue. We explored the impact of screened core miRNA and mRNA on cell proliferation, invasion, and migration of glioma. An miRNA expression profile dataset (GSE90603) and a transcriptome profile dataset (GSE90598) were downloaded from combined miRNA-mRNA microarray chips in the Gene Expression Omnibus (GEO) database. Overall, 59 differentially expressed miRNAs (DEMs) and 419 differentially expressed genes (DEGs) were identified using the R limma software package. FunRich software was used to predict DEM target genes and miRNA-gene pairs, and Perl software was used to find overlapping genes between DEGs and DEM target genes. There were 129 overlapping genes regulated by nine miRNAs between target genes of the DEMs and DEGs. The Chinese Glioma Genome Atlas(CGGA) was analyzed in order to identify miRNAs with diagnostic and prognostic significance. MiR-139-5p, miR-137, and miR-338-3p were validated to be significantly linked to prognosis in glioma patients. Finally, we validated that miR-139-5p affected glioma malignant biological behavior via targeting gamma-aminobutyric acid A receptor alpha 1(GABRA1) through rescue experiments. Low miR-139-5p expression was correlated with survival probability and World Health Organization (WHO) grade. MiR-139-5p overexpression inhibited cell proliferation, migration, and invasion of glioma in vitro. GABRA1 was identified as a functional downstream target of miR-139-5p. Decreased GABRA1 expression was related to similar biological roles as miR-139-5p overexpression while upregulation of GABRA1 effectively reversed the inhibition effects of miR-139-5p. These results demonstrate a novel axis for miR-139-5p/GABRA1 in glioma progression and provide potential prognostic predictors and therapeutic target for glioma patients.

MiR-200c Inhibits the Tumor Progression of Glioma Via Targeting Moesin.

A Predicted Mir-27A-mediated Network Identifies a Signature of Glioma.

Transcriptional Repression of Mir-200 Family Members by Nanog in Colon Cancer Cells Induces Epithelial Mesenchymal Transition (Emt)

miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase.

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

MiR-302c-3p Suppresses Invasion and Proliferation of Glioma Cells Via Down-Regulating Metadherin (MTDH) Expression.

MicroRNA‑218 Inhibits the Malignant Phenotypes of Glioma by Modulating the TNC/AKT/AP‑1/TGFβ1 Feedback Signaling Loop

Mirna-182 Regulated Mtss1 Inhibits Proliferation And Invasion In Glioma Cells

Mir-508-5p Inhibits the Progression of Glioma by Targeting Glycoprotein Non-Metastatic Melanoma B

miR200c attenuates P-gp-mediated MDR and metastasis by targeting JNK2/c-Jun signaling pathway in colorectal cancer

MicroRNA-206 Inhibited the Progression of Glioblastoma Through BCL-2.

miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.

MicroRNA-509-3p Inhibits Cell Proliferation and Invasion Via Downregulation of X-linked Inhibitor of Apoptosis in Glioma.

Mir-212-5p Suppresses Glioma Development Via Targeting SUMO2

Reduced Expression of Microrna-206 Regulates Cell Proliferation Via Cyclind2 in Gliomas

GTF2E2 Downregulated by Mir-340-5p Inhibits the Malignant Progression of Glioblastoma

Mir-188 Inhibits Glioma Cell Proliferation and Cell Cycle Progression Through Targeting Β-Catenin.

Microrna-300 Inhibited Glioblastoma Progression Through Rock1

miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L

MicroRNA-206 Attenuates Glioma Cell Proliferation, Migration, and Invasion by Blocking the WNT/β-catenin Pathway Via Direct Targeting of Frizzled 7 Mrna.

Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1